Päivi Lähteenmäki profile picture
Päivi
Lähteenmäki
Adjunct Professor, Department of Clinical Medicine
MD, PhD Docent (Adjunct professor); Medicine (Department of Clinical Medicine)

Contact

Areas of expertise

Pediatric and adolescent hematology and oncology
Late-effects of cancer treatment at an early age
Quality improvement and registration.

Biography

Päivi Lähteenmäki graduated from the Medical School at the University of Turku in 1984, where she also specialized in Pediatrics and PediatricHematology and Oncology. She defended her thesis in 1999 on Effects of childhood cancer on patients and their families - physical and psychosocial aspects. She worked in 2002 as a post-doc Clinical and Research Fellow at Bristol Sick Children’s Hospital BMT Unit, Bristol, UK. Subsequently, she has worked as a Consultant at the Department of Pediatrics, University of Turku. Since 2008, she has been Docent (Adjunct Professor) of Pediatric Hematology and Oncology at the Faculty of Medicine, University of Turku, and Head of the Division of Pediatric and Adolescent Hematology/Oncology at Turku University Hospital in Turku, Finland. Currently she works also as the Chief of the Swedish Childhood Cancer Registry at Karolinska Institutet in Stockholm, Sweden.

During the years, Päivi Lähteenmäki has served as the chairman or a board member of the Nordic Society of Pediatric Hematology and Oncology as well as the Finnish Association of Pediatric Hematology and Oncology. In 2012-2014, She was the chair of a group planning the establishment of childhood cancer late-effect clinics in Finland. In 2016, she was awarded the Finnish Cancer Association Price, Oncologist of the year in Finland.

Teaching

Since 2008, clinical pediatric hematology and oncology at the Department of Pediatrics and Adolescent Medicine, University of Turku.

Research

Päivi Lähteenmäki´s major research interest lies in the late-effects of childhood cancer. In year 2000, she founded her own research group and initiated a long-term research project called “Health and Quality of Life in Patients with Early Age Onset Cancer” including the epidemiology, diagnosis, prevention, and overall societal impact of the late sequelae of cancer and its treatments. Päivi Lähteenmäki has been actively involved in international research collaboration. In 2006, she started a collaboration with NIH funded GCCT (Genetic consequences of cancer therapies) consortium, followed by a Nordic project ALiCCS (Adult life in childhood cancer survivors), and an EU funded project PanCareSurFup (PanCare Childhood and Adolescent Cancer Survivor Care and Follow-Up Studies). In 2018, two new Nordic collaborations started (PACCS Physical activity in childhood cancer survivors; PACS Pregnancy associated cancer). She is also a principal investigator in NOPHO-CARE (A Nordic study on epidemiology, biology, treatment and survival of children with cancer and severe hematological diseases).

Publications

Sort by:

Risk of digestive cancers in a cohort of 69 460 five-year survivors of childhood cancer in Europe: The PanCareSurFup study (2020)

Gut
C Reulen, Kwok F Wong, Chloe J Bright, David L Winter, Daniela Alessi, M Allodji, Francesca Bagnasco, Edit Bárdi,, Andrea Bautz, Julianne Byrne, Elizabeth AM Feijen, Miranda M Fidler-Benaoudia, Ibrahim Diallo, Stanislaw Garwicz, Desiree Grabow, Thorgerdur Gudmundsdottir, Joyeeta Guha, Nadia Haddy, Stine Høgsholt, Moncilo Jankovic, Peter Kaatsch, Melanie Kaiser, Rahel Kuonen, Helena Linge, Hilde Øfstaas, Cecile M Ronckers, Eva-Maria Hau, Roderick Skinner, Flora E van Leeuwen, Jop C Teepen, Cristina Veres, Wael Zrafi, Ghazi Debiche, Damien Llanas, Monica Terenziani, Giao Vu-Bezin, Finn Wesenberg, Thomas Wiebe, Carlotta Sacerdote, Zsuzsanna Jakab, Riccardo Haupt, Päivi M Lähteenmäki, Lorna Zadravec Zaletel, Claudia E Kuehni, Jeanette F Winther, Florent de Vathaire, Leontien C Kremer, Lars Hjorth, Michael M Hawkins
(A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä)